Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.

Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, Rahbar H, Sung JS, Jacobs C, Harvey JA, Nicholson MH, Ward RC, Holt J, Prather A, Miller KD, Schnall MD, Kuhl CK.

JAMA. 2020 Feb 25;323(8):746-756. doi: 10.1001/jama.2020.0572.

PMID:
32207768
2.

Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round.

Conant EF, Zuckerman SP, McDonald ES, Weinstein SP, Korhonen KE, Birnbaum JA, Tobey JD, Schnall MD, Hubbard RA.

Radiology. 2020 Mar 10:191751. doi: 10.1148/radiol.2020191751. [Epub ahead of print]

PMID:
32154771
3.

Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.

Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, Rahbar H, Sung JS, Jacobs C, Harvey JA, Nicholson MH, Ward RC, Holt J, Prather A, Miller KD, Schnall MD, Kuhl CK.

JAMA. 2020 Feb 25;323(8):746-756. doi: 10.1001/jama.2020.0572. Erratum in: JAMA. 2020 Mar 24;323(12):1194.

PMID:
32096852
4.

1H magnetic resonance spectroscopy of 2H-to-1H exchange quantifies the dynamics of cellular metabolism in vivo.

Rich LJ, Bagga P, Wilson NE, Schnall MD, Detre JA, Haris M, Reddy R.

Nat Biomed Eng. 2020 Mar;4(3):335-342. doi: 10.1038/s41551-019-0499-8. Epub 2020 Jan 27.

PMID:
31988460
5.

Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.

Rendle KA, Burnett-Hartman AN, Neslund-Dudas C, Greenlee RT, Honda S, Elston Lafata J, Marcus PM, Cooley ME, Vachani A, Meza R, Oshiro C, Simoff MJ, Schnall MD, Beaber EF, Doria-Rose VP, Doubeni CA, Ritzwoller DP.

Cancer Prev Res (Phila). 2020 Feb;13(2):129-136. doi: 10.1158/1940-6207.CAPR-19-0378. Epub 2019 Dec 23.

PMID:
31871221
6.

Sugar alcohol provides imaging contrast in cancer detection.

Bagga P, Wilson N, Rich L, Marincola FM, Schnall MD, Hariharan H, Haris M, Reddy R.

Sci Rep. 2019 Jul 31;9(1):11092. doi: 10.1038/s41598-019-47275-5.

7.

Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.

Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA.

J Natl Cancer Inst. 2020 Mar 1;112(3):238-246. doi: 10.1093/jnci/djz137.

PMID:
31292633
8.

An Initiative to Reduce Unnecessary Gadolinium-Based Contrast in Multiple Sclerosis Patients.

Rudie JD, Mattay RR, Schindler M, Steingall S, Cook TS, Loevner LA, Schnall MD, Mamourian AC, Bilello M.

J Am Coll Radiol. 2019 Sep;16(9 Pt A):1158-1164. doi: 10.1016/j.jacr.2019.04.005. Epub 2019 May 16.

PMID:
31092348
9.

Comparison of Study Activity Times for "Full" versus "Fast MRI" for Breast Cancer Screening.

Borthakur A, Weinstein SP, Schnall MD, Conant EF.

J Am Coll Radiol. 2019 Aug;16(8):1046-1051. doi: 10.1016/j.jacr.2019.01.004. Epub 2019 Apr 8.

PMID:
30975607
10.

Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.

Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, Haas JS, Lowry KP, Stout NK, Trentham-Dietz A, diFlorio-Alexander RM, Li CI, Schnall MD, Onega T, Sprague BL; Population-based Research Optimizing Screening Through Personalized Regimen (PROSPR) Consortium.

JAMA Oncol. 2019 May 1;5(5):635-642. doi: 10.1001/jamaoncol.2018.7078.

11.

Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).

Rahbar H, Zhang Z, Chenevert TL, Romanoff J, Kitsch AE, Hanna LG, Harvey SM, Moy L, DeMartini WB, Dogan B, Yang WT, Wang LC, Joe BN, Oh KY, Neal CH, McDonald ES, Schnall MD, Lehman CD, Comstock CE, Partridge SC.

Clin Cancer Res. 2019 Mar 15;25(6):1756-1765. doi: 10.1158/1078-0432.CCR-18-2967. Epub 2019 Jan 15.

12.

Current Activities of the Coalition of Cancer Cooperative Groups.

Bertagnolli MM, Blaney SM, Blanke CD, Curran WJ, Dancey J, Mannel RS, O'Dwyer PJ, Schnall MD, Wolmark N; Coalition of Cancer Cooperative Groups.

J Natl Cancer Inst. 2019 Jan 1;111(1):11-18. doi: 10.1093/jnci/djy190.

13.

Improving Performance by Using a Radiology Extender.

Borthakur A, Kneeland JB, Schnall MD.

J Am Coll Radiol. 2018 Sep;15(9):1300-1303. doi: 10.1016/j.jacr.2018.03.051. Epub 2018 May 8. No abstract available.

PMID:
29752136
14.

MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.

Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM; ACRIN 6657 Trial Team and I-SPY Investigators Network.

AJR Am J Roentgenol. 2018 Jun;210(6):1376-1385. doi: 10.2214/AJR.17.18323. Epub 2018 Apr 30.

15.

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.

Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K.

CA Cancer J Clin. 2018 May;68(3):199-216. doi: 10.3322/caac.21452. Epub 2018 Mar 30.

16.

Characterizing and eliminating errors in enhancement and subtraction artifacts in dynamic contrast-enhanced breast MRI: Chemical shift artifact of the third kind.

Derakhshan JJ, McDonald ES, Siegelman ES, Schnall MD, Wehrli FW.

Magn Reson Med. 2018 Apr;79(4):2277-2289. doi: 10.1002/mrm.26879. Epub 2017 Aug 24.

17.

BI-RADS Category 3 Comparison: Probably Benign Category after Recall from Screening before and after Implementation of Digital Breast Tomosynthesis.

McDonald ES, McCarthy AM, Weinstein SP, Schnall MD, Conant EF.

Radiology. 2017 Dec;285(3):778-787. doi: 10.1148/radiol.2017162837. Epub 2017 Jul 17.

18.

Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.

Bagga P, Haris M, D'Aquilla K, Wilson NE, Marincola FM, Schnall MD, Hariharan H, Reddy R.

J Transl Med. 2017 May 30;15(1):119. doi: 10.1186/s12967-017-1221-9.

19.

Implementation of an Automated Radiology Recommendation-Tracking Engine for Abdominal Imaging Findings of Possible Cancer.

Cook TS, Lalevic D, Sloan C, Chadalavada SC, Langlotz CP, Schnall MD, Zafar HM.

J Am Coll Radiol. 2017 May;14(5):629-636. doi: 10.1016/j.jacr.2017.01.024. Epub 2017 Mar 17. No abstract available.

PMID:
28325488
20.

No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy.

Vapiwala N, Hwang WT, Kushner CJ, Schnall MD, Freedman GM, Solin LJ.

Cancer. 2017 Apr 15;123(8):1324-1332. doi: 10.1002/cncr.30479. Epub 2016 Dec 16.

21.

MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.

Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM; ACRIN Trial team ISPY-1 Investigators.

J Magn Reson Imaging. 2017 Jul;46(1):290-302. doi: 10.1002/jmri.25560. Epub 2016 Dec 16.

22.

Expanding the Scope of an Automated Radiology Recommendation-Tracking Engine: Initial Experiences and Lessons Learned.

Licurse MY, Lalevic D, Zafar HM, Schnall MD, Cook TS.

J Digit Imaging. 2017 Apr;30(2):156-162. doi: 10.1007/s10278-016-9912-y.

23.

Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial.

Stillman AE, Gatsonis C, Lima JA, Black WC, Cormack J, Gareen I, Hoffmann U, Liu T, Mavromatis K, Schnall MD, Udelson JE, Woodard PK.

Am Heart J. 2016 Sep;179:19-28. doi: 10.1016/j.ahj.2016.06.003. Epub 2016 Jun 17.

24.

Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study.

Sprague BL, Conant EF, Onega T, Garcia MP, Beaber EF, Herschorn SD, Lehman CD, Tosteson AN, Lacson R, Schnall MD, Kontos D, Haas JS, Weaver DL, Barlow WE; PROSPR Consortium.

Ann Intern Med. 2016 Oct 4;165(7):457-464. doi: 10.7326/M15-2934. Epub 2016 Jul 19.

25.

The Dose-Response Effects of Aerobic Exercise on Body Composition and Breast Tissue among Women at High Risk for Breast Cancer: A Randomized Trial.

Brown JC, Kontos D, Schnall MD, Wu S, Schmitz KH.

Cancer Prev Res (Phila). 2016 Jul;9(7):581-8. doi: 10.1158/1940-6207.CAPR-15-0408. Epub 2016 Apr 20.

26.

Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium.

Conant EF, Beaber EF, Sprague BL, Herschorn SD, Weaver DL, Onega T, Tosteson AN, McCarthy AM, Poplack SP, Haas JS, Armstrong K, Schnall MD, Barlow WE.

Breast Cancer Res Treat. 2016 Feb;156(1):109-16. doi: 10.1007/s10549-016-3695-1. Epub 2016 Mar 1.

27.

Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.

Armstrong K, Kim JJ, Halm EA, Ballard RM, Schnall MD.

Cancer. 2016 May 1;122(9):1338-42. doi: 10.1002/cncr.29937. Epub 2016 Feb 29.

28.

Erratum: Lactate Chemical Exchange Saturation Transfer (LATEST) Imaging in vivo: A Biomarker for LDH Activity.

DeBrosse C, Nanga RP, Bagga P, Nath K, Haris M, Marincola F, Schnall MD, Hariharan H, Reddy R.

Sci Rep. 2016 Feb 25;6:21813. doi: 10.1038/srep21813. No abstract available.

29.

Lactate Chemical Exchange Saturation Transfer (LATEST) Imaging in vivo A Biomarker for LDH Activity.

DeBrosse C, Nanga RP, Bagga P, Nath K, Haris M, Marincola F, Schnall MD, Hariharan H, Reddy R.

Sci Rep. 2016 Jan 22;6:19517. doi: 10.1038/srep19517. Erratum in: Sci Rep. 2016;6:21813.

30.

Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.

Hylton NM, Gatsonis CA, Rosen MA, Lehman CD, Newitt DC, Partridge SC, Bernreuter WK, Pisano ED, Morris EA, Weatherall PT, Polin SM, Newstead GM, Marques HS, Esserman LJ, Schnall MD; ACRIN 6657 Trial Team and I-SPY 1 TRIAL Investigators.

Radiology. 2016 Apr;279(1):44-55. doi: 10.1148/radiol.2015150013. Epub 2015 Dec 1.

31.

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.

Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S.

Eur Urol. 2016 Jan;69(1):16-40. doi: 10.1016/j.eururo.2015.08.052. Epub 2015 Oct 1.

32.

Code Abdomen: An Assessment Coding Scheme for Abdominal Imaging Findings Possibly Representing Cancer.

Zafar HM, Chadalavada SC, Kahn CE Jr, Cook TS, Sloan CE, Lalevic D, Langlotz CP, Schnall MD.

J Am Coll Radiol. 2015 Sep;12(9):947-50. doi: 10.1016/j.jacr.2015.04.005. Epub 2015 Jun 27. No abstract available.

33.

Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures.

Chung SH, Feldman MD, Martinez D, Kim H, Putt ME, Busch DR, Tchou J, Czerniecki BJ, Schnall MD, Rosen MA, DeMichele A, Yodh AG, Choe R.

Breast Cancer Res. 2015 May 27;17:72. doi: 10.1186/s13058-015-0578-z.

34.

Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular Carcinoma.

Gade TP, Hunt SJ, Harrison N, Nadolski GJ, Weber C, Pickup S, Furth EE, Schnall MD, Soulen MC, Celeste Simon M.

J Vasc Interv Radiol. 2015 Aug;26(8):1229-37. doi: 10.1016/j.jvir.2015.02.006. Epub 2015 Apr 8.

35.

Opportunities for the ECOG-ACRIN Cancer Research Group within the new National Clinical Trials Network.

Comis RL, Schnall MD.

Semin Oncol. 2015 Feb;42(1):1-3. doi: 10.1053/j.seminoncol.2014.12.017. Epub 2014 Dec 20. No abstract available.

PMID:
25726046
36.

A Dedicated Breast Positron Emission Tomography Scanner: Proof of Concept.

Srinivas SM, Greene LR, Currie GM, Freifelder RH, Reddin JR, Alavi A, Schnall MD, Karp JS.

J Med Imaging Radiat Sci. 2014 Dec;45(4):435-439. doi: 10.1016/j.jmir.2014.06.005.

PMID:
31051916
37.

Assessment of follow-up completeness and notification preferences for imaging findings of possible cancer: what happens after radiologists submit their reports?

Sloan CE, Chadalavada SC, Cook TS, Langlotz CP, Schnall MD, Zafar HM.

Acad Radiol. 2014 Dec;21(12):1579-86. doi: 10.1016/j.acra.2014.07.006. Epub 2014 Aug 30.

38.

Optically measured microvascular blood flow contrast of malignant breast tumors.

Choe R, Putt ME, Carlile PM, Durduran T, Giammarco JM, Busch DR, Jung KW, Czerniecki BJ, Tchou J, Feldman MD, Mies C, Rosen MA, Schnall MD, DeMichele A, Yodh AG.

PLoS One. 2014 Jun 26;9(6):e99683. doi: 10.1371/journal.pone.0099683. eCollection 2014.

39.

Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.

Rahbar H, Hanna LG, Gatsonis C, Mahoney MC, Schnall MD, DeMartini WB, Lehman CD.

Radiology. 2014 Oct;273(1):53-60. doi: 10.1148/radiol.14132029. Epub 2014 Jun 16.

40.

Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.

Agner SC, Rosen MA, Englander S, Tomaszewski JE, Feldman MD, Zhang P, Mies C, Schnall MD, Madabhushi A.

Radiology. 2014 Jul;272(1):91-9. doi: 10.1148/radiol.14121031. Epub 2014 Mar 10.

41.

Blood flow reduction in breast tissue due to mammographic compression.

Busch DR, Choe R, Durduran T, Friedman DH, Baker WB, Maidment AD, Rosen MA, Schnall MD, Yodh AG.

Acad Radiol. 2014 Feb;21(2):151-61. doi: 10.1016/j.acra.2013.10.009.

42.

Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers.

Lehman CD, Blume JD, DeMartini WB, Hylton NM, Herman B, Schnall MD.

AJR Am J Roentgenol. 2013 Jun;200(6):W683-9. doi: 10.2214/AJR.11.8394.

43.

Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population.

Daye D, Keller B, Conant EF, Chen J, Schnall MD, Maidment AD, Kontos D.

Acad Radiol. 2013 May;20(5):635-46. doi: 10.1016/j.acra.2012.12.016.

44.

Automated chest wall line detection for whole-breast segmentation in sagittal breast MR images.

Wu S, Weinstein SP, Conant EF, Schnall MD, Kontos D.

Med Phys. 2013 Apr;40(4):042301. doi: 10.1118/1.4793255.

45.

Future vision for the quality assurance of oncology clinical trials.

Fitzgerald TJ, Bishop-Jodoin M, Bosch WR, Curran WJ, Followill DS, Galvin JM, Hanusik R, King SR, Knopp MV, Laurie F, O'Meara E, Michalski JM, Saltz JH, Schnall MD, Schwartz L, Ulin K, Xiao Y, Urie M.

Front Oncol. 2013 Mar 15;3:31. doi: 10.3389/fonc.2013.00031. eCollection 2013.

46.

Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy.

Busch DR, Choe R, Rosen MA, Guo W, Durduran T, Feldman MD, Mies C, Czerniecki BJ, Tchou J, Demichele A, Schnall MD, Yodh AG.

Biomed Opt Express. 2013 Jan 1;4(1):105-21. doi: 10.1364/BOE.4.000105. Epub 2012 Dec 14.

47.

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Hylton NM, Blume JD, Bernreuter WK, Pisano ED, Rosen MA, Morris EA, Weatherall PT, Lehman CD, Newstead GM, Polin S, Marques HS, Esserman LJ, Schnall MD; ACRIN 6657 Trial Team and I-SPY 1 TRIAL Investigators.

Radiology. 2012 Jun;263(3):663-72. doi: 10.1148/radiol.12110748.

48.

Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.

Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD.

Radiology. 2010 Jun;255(3):731-7. doi: 10.1148/radiol.10081712.

49.

Computer aided automatic detection of malignant lesions in diffuse optical mammography.

Busch DR, Guo W, Choe R, Durduran T, Feldman MD, Mies C, Rosen MA, Schnall MD, Czerniecki BJ, Tchou J, DeMichele A, Putt ME, Yodh AG.

Med Phys. 2010 Apr;37(4):1840-9.

50.

Multimodality screening of high-risk women: a prospective cohort study.

Weinstein SP, Localio AR, Conant EF, Rosen M, Thomas KM, Schnall MD.

J Clin Oncol. 2009 Dec 20;27(36):6124-8. doi: 10.1200/JCO.2009.24.4277. Epub 2009 Nov 2.

Supplemental Content

Loading ...
Support Center